The association of depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy (HAART) was evaluated in 135 HIV-infected persons. Thirty percent reported nonadherence to HAART. Depressive symptoms (assessed with the Montgomery-Asberg Depression Rating Scale) and neurocognitive impairment (assessed with a neuropsychological test battery) were documented in 24% and 12%, respectively, of the study participants. Nonadherence to HAART was independently associated with worse depression rating scale scores (odds ratio = 1.05, 95% confidence interval [CI] = 1.00-1.10), acquisition of HIV through injection of drugs (odds ratio = 2.59, 95% CI = 1.05-6.39), and complaints about impairment of sexual activity (odds ratio = 6.62, 95% CI = 1.16-37.6). The presence of depressive symptoms, but not neurocognitive impairment, was associated with nonadherence.
The relationship of depressive symptoms, neurocognitive impairment and HAART adherence among HIV-infected persons / A. Ammassari, A. Antinori, M.S. Aloisi, M.P. Trotta, R. Murri, L. Bartoli, A. d’Arminio Monforte, A.W. Wu, F. Starace. - In: PSYCHOSOMATICS. - ISSN 0033-3182. - 45:5(2004), pp. 394-402. [10.1176/appi.psy.45.5.394]
The relationship of depressive symptoms, neurocognitive impairment and HAART adherence among HIV-infected persons
A. d’Arminio Monforte;
2004
Abstract
The association of depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy (HAART) was evaluated in 135 HIV-infected persons. Thirty percent reported nonadherence to HAART. Depressive symptoms (assessed with the Montgomery-Asberg Depression Rating Scale) and neurocognitive impairment (assessed with a neuropsychological test battery) were documented in 24% and 12%, respectively, of the study participants. Nonadherence to HAART was independently associated with worse depression rating scale scores (odds ratio = 1.05, 95% confidence interval [CI] = 1.00-1.10), acquisition of HIV through injection of drugs (odds ratio = 2.59, 95% CI = 1.05-6.39), and complaints about impairment of sexual activity (odds ratio = 6.62, 95% CI = 1.16-37.6). The presence of depressive symptoms, but not neurocognitive impairment, was associated with nonadherence.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.